Throughout its 300-year history, ONO has dedicated itself to developing innovative and breakthrough pharmaceutical products.

1717 The first Ichibei Ono set up the apothecary “Fushimiya Ichibei” in Doshomachi, Osaka.
1934 Reorganized to an unlimited partnership, and changed the name to “Ono Ichibei Shoten”.
1947 ONO PHARMACEUTICAL CO., LTD. was established.
1968 Completion of the Central Research Institute (Current the Minase Research Institute).
Made a world-first success of total synthesis of prostaglandin (PG) as a public corporation.
1978 Completion of the new head office building (Current the head branch)
1982 The London office was opened in the United Kingdom.
1990 The Seattle office was opened in the U.S.A.
1994 The Seoul office was opened in South Korea (Later Seoul Branch).
1998 ONO PHARMA UK LTD. and ONO PHARMA USA, INC. were established. (The London office and the Seattle office developed into ONO PHARMA UK LTD. and ONO PHARMA USA, INC., respectively.)
2003 The Tsukuba Research Institute was opened. Completion of the new Head Office building.
2013 ONO PHARMA KOREA CO., LTD. was established in South Korea
2014 ONO PHARMA TAIWAN CO., LTD. was established in Taiwan